Mok Chi Chiu, Mak Anselm, Chu Wai Po, To Chi Hung, Wong Sik Nin
From Department of Medicine (CCM, AM, CHT) and Department of Pediatrics (WPC, SNW), Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong.
Medicine (Baltimore). 2005 Jul;84(4):218-224. doi: 10.1097/01.md.0000170022.44998.d1.
We conducted the current study to determine the clinical determinants of survival and the survival rates in an unselected cohort of Chinese patients with new-onset systemic lupus erythematosus (SLE), including all age-groups. Patients were those newly diagnosed as having SLE or referred within 6 months of diagnosis to the departments of medicine, geriatrics, and pediatrics at Tuen Mun Hospital, Hong Kong, between 1991 and 2003. Patients under the care of all specialists were included for analysis. We obtained demographic data, presenting and cumulative clinical features, disease activity, and serial damage scores. For patients who died or were lost to follow-up, data were censored at the last clinic visit. Survival over time was studied by the Kaplan-Meier method, and factors predictive of mortality were evaluated by the Cox proportional hazard model. We studied 285 new-onset SLE patients (92% women). All were ethnic Chinese and fulfilled at least 4 of the American College of Rheumatology criteria for SLE. The mean age of SLE onset was 30.0 +/- 13.5 years. Fifty (18%) patients had first onset of SLE before the age of 16 years (childhood onset), and 22 (8%) had disease onset after the age of 50 years (late onset); 213 (75%) patients had disease onset between the ages of 16 and 50 years (adult onset). Twenty-nine (10%) patients died (4 from the childhood-onset group, 6 from the late-onset group, and 19 from the adult-onset group) and 18 (6%) patients were lost to follow-up. The overall 5-, 10-, and 15-year survival rates were 92%, 83%, and 80%, respectively. Survival was significantly worse in late-onset patients: 5-, 10-, and 15-year survival rates were 66%, 44%, and 44%, respectively; p < 0.0001. Infection was the main cause of death (55%), followed by cardiovascular (17%) and cerebrovascular complications (14%). Unfavorable factors for survival on univariate analysis were increasing age, damage scores at 1 year, and the use of high-dose corticosteroids. Cox regression revealed that damage scores at 1 year and hematologic manifestations were independent predictors of mortality. Long-term survival of Chinese SLE patients is comparable to that reported for white patients in the 1990s. Late-onset SLE patients have the worst prognosis. Early damage predicts mortality.
我们开展了本研究,以确定中国新发性系统性红斑狼疮(SLE)患者(涵盖所有年龄组)未经筛选队列的生存临床决定因素及生存率。患者为1991年至2003年间在香港屯门医院内科、老年病科和儿科新诊断为SLE或在诊断后6个月内转诊的患者。纳入所有专科医生诊治的患者进行分析。我们获取了人口统计学数据、当前及累积临床特征、疾病活动度和系列损伤评分。对于死亡或失访的患者,数据在最后一次门诊就诊时进行截尾。采用Kaplan-Meier法研究随时间的生存率,并通过Cox比例风险模型评估预测死亡的因素。我们研究了285例新发性SLE患者(92%为女性)。所有患者均为华裔,且至少符合美国风湿病学会SLE标准中的4条。SLE发病的平均年龄为30.0±13.5岁。50例(18%)患者在16岁之前首次发生SLE(儿童期发病),22例(8%)患者在50岁之后发病(晚期发病);213例(75%)患者在16至50岁之间发病(成年期发病)。29例(10%)患者死亡(儿童期发病组4例,晚期发病组6例,成年期发病组19例),18例(6%)患者失访。总体5年、10年和15年生存率分别为92%、83%和80%。晚期发病患者的生存率显著更差:5年、10年和15年生存率分别为66%、44%和44%;p<0.0001。感染是主要死亡原因(55%),其次是心血管(17%)和脑血管并发症(14%)。单因素分析中不利于生存的因素为年龄增加、1年时的损伤评分以及使用高剂量糖皮质激素。Cox回归显示1年时的损伤评分和血液学表现是死亡的独立预测因素。中国SLE患者的长期生存率与20世纪90年代报道的白人患者相当。晚期发病的SLE患者预后最差。早期损伤可预测死亡。